← All trials
NCT00448669
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2007
- Primary completion
- Mar 1, 2011
- Completion date
- Mar 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 1219
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Gilead SciencesCollaborator
- Botswana Ministry of HealthCollaborator
- Centers for Disease Control and Prevention (CDC)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.